Aminopropanol derivatives, processes for the preparation thereof

Details Aminopropanol derivatives, processes for the preparation thereof Aminopropanol derivatives, processes for the preparation thereof

1987-09-21

1989-09-05

Sutto, Anton H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548469, 548483, 548484, 548485, 548486, 548491, 548493, 548503, 548505, 548305, 548325, 548329, 548327, 548330, 548444, 546201, 546146, 546150, 546157, 546158, 546221, 540602, 514212, 514323, 514414, 514415, 514419, 5142242, 514259, 514307, 514312, 514319, 514387, 514394, 514395, 514456, 514457, 514465, 514509, 514470, 514434, 544 52, 544286, 549 15, 549289, 549408, 549438, 549464, 549465, 549512, 549551, 549555, 558414, 558482, 558483, 558484, 560169, 564123, 564201, C07D20934, C07D20930, C07D20908, C07D21

Patent

active

048639494

ABSTRACT:
The present invention provides compounds of the general formula: ##STR1## wherein Ar is a substituted or unsubstituted aromatic or heteroaromatic radical, A is a straight-chained or branched alkylene chain containing up to 8 carbon atoms, a --CH.sub.2 -- group of which can be replaced by a cycloalkylene radical containing 3 to 7 carbon atoms, B is a straight-chained mono- or bicyclic, optionally branched, saturated or unsaturated alkylene chain containing up to 12 carbon atoms, a --CH.sub.2 -- group of which can be replaced by a cycloalkylene radical containing 3 to 7 carbon atoms and/or up to two --CH.sub.2 -- groups of which can be replaced by an oxygen or a sulphur atom or by an --S(.dbd.O) or --S(.dbd.O).sub.2 group, X is a valency bond, an oxygen atom or an --NR.sup.1 group, in which R.sup.1 is a hydrogen atom or a straight-chained or branched, saturated or unsaturated alkyl or nitroxyalkyl radical containing up to 6 carbon atoms or R.sup.1, together with the nitrogen atom of the --NR.sup.1 -- group and a --CH.sub.2 -- group of the chain B, can form a heteroaliphatic ring containing 4 to 6 carbon atoms and n is 1, 2 or 3; and the physiologically acceptable salts thereof. The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them. Furthermore, the present invention is concerned with the use of these compounds for the treatment and/or prophylaxis of heart and circulatory diseases.

REFERENCES:
patent: 3644469 (1972-02-01), Koppe et al.
patent: 3911136 (1975-10-01), Ferrari
patent: 3928412 (1975-12-01), Smith
patent: 4086357 (1978-04-01), Large et al.
patent: 4288452 (1981-09-01), Sombroek et al.
patent: 4419363 (1983-12-01), Smith
Ahlmark et al., The Lancet, p. 1563, (12/28/74).
Ahlmark et al., Europ. J. Clin. Pharmacol., , 10, pp. 77-83, (1976).
Chamberlain et al., Postgraduate Medical Journal, 52, (Suppl. 4), pp. 153-154, (1976).
Bartsch et al., Drug Research, 27, pp. 2319-2322, (1977).
Abstract for Japan Patent No. 56/077257, (6/25/81).
Derwent Abstract #86-029678/05 for DE Patent No. 3426419, (1/23/86), (1986).
Abstract for Swiss Patent No. 636856, (6/30/83).

Affiliated with

Also associated with

Rating

Aminopropanol derivatives, processes for the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aminopropanol derivatives, processes for the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopropanol derivatives, processes for the preparation thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-243805